Study on clarification of unregulated gene expression to genome network by dioxin and related compounds using a human alveolar carcinoma cell line
Study on clarification of unregulated gene expression to genome network by dioxin and related compounds using a human alveolar carcinoma cell line
批准号:
13672351
负责人:
TEZUKA Masakatsu
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The arylhydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates a spectrum of toxic and biological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) and related compounds. Although the physiological ligand for the AhR has not yet been identified, several reports have suggested that the AhR may play important roles not only in the regulation of xenobiotic metabolism but also in the maintenance of homeostatic functions.In this study, we first investigated the role of AhR on cell proliferation. The cell proliferation of A549 cells, a human alveolar carcinoma cell line, was enhanced by the treatment with the AhR-ligand, β -naphthoflavone. The enhancement effect was disappeared by the co-treatment with the AhR-antagonist, α-naphthoflavone. Next, in order to obtain direct evidence that the AhR regulates cell proliferation, we isolated the clones that overexpress the AhR. These clones grow faster than control cells, and the rate of growth is proportional to t … More he amount of the AhR. Cell cycle analysis revealed that the acceleration of cell growth by overexpression of the AhR is most probably due to shortening of the late M to S phases. Studies on the expression profiles of cell cycle regulators showed that the AhR or AhR ligand induces the expression of DP2, PCNA, and RFC38. DP2 is the transcription factor that forms the functional dimer with E2F and regulates the expression of several genes involved in DNA synthesis. Interestingly, both PCNA and RFC38 are target genes of E2F and the DP complex. E2F activity was substantially increased in both the AhR-overexpressing cells and the AhR-agonist treated cells, suggesting that AhR-activated E2F/DP2 may induce the expression of PCNA and RFC38 and subsequent DNA synthesis. Down-regulation of the expression of the Arnt by RNAi diminished the effects of the AhR on the cell proliferation of the A549 cells. Consequently, we conclude that the AhR, presumably in collaboration with the Arnt, activates the DNA synthesis and the subsequent cell proliferation in A549 cells. Less
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
S. Shimba, M. Tezuka et al.: "Overexpression of the Aryl Hydrocarbon Receptor (AhR) Accelerates the Cell Proliferation of A549 Cells"J. Biochem.. 132. 795-802 (2002)
S. Shimba、M. Tezuka 等人:“芳基烃受体 (AhR) 的过度表达加速 A549 细胞的细胞增殖”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Shimba, M.Tezuka et al.: "Overexpression of the Aryl Hydrocarbon Receptor (AhR) Accelerates the Cell Proliferation of A549 Cells"Journal of Biochemistry. 132. 795-802 (2002)
S.Shimba、M.Tezuka 等人:“芳基烃受体 (AhR) 的过度表达加速 A549 细胞的细胞增殖”生物化学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Transcriptional regulation mechanisms of arylhydrocarbon receptor(AhR), Arnt and E2F genes on proliferation process in A549 cells as promoter activity in carcinogenesis by dioxin
-
批准号:19590127
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:TEZUKA Masakatsu
-
依托单位:
Transcriptional regulation of arylhydrocarbon receptor (AhR), Arnt and E2F genes on proliferation process in A549 cells by dioxin and its mechanism.
-
批准号:17590109
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:TEZUKA Masakatsu
-
依托单位:
A disturbed regulation of multi-differentiation in human mesenchymal stem cells by dioxin and its mechanism
-
批准号:15590114
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2003
-
负责人:TEZUKA Masakatsu
-
依托单位:
Study of gene expression on toxicity of dioxin in cultured cells
-
批准号:11672231
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:1999
-
负责人:TEZUKA Masakatsu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于IDO1泛素化逃逸-KYN-AHR通路解析构建哮喘-慢阻肺重叠人工智能诊疗模型的多中心联合研究
-
批准号:2026JJ80049
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:梁彦超
-
依托单位:
慢性应激下L. murinus代谢物吲哚-3-乙酸(IAA)通过AhR-CTRP9改善胰岛素抵抗的机制研究
-
批准号:JCZRQNB202600767
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
5-HIAA经激活巨噬细胞AhR/Slc1a2通路改善脂肪炎症的作用和机制
-
批准号:2026JJ60584
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘小欢
-
依托单位:
基于肠-肺轴研究君仁补肺益心颗粒调节RELM-β/吲哚丙酸/AhR治疗心肺气虚兼血瘀证HPH小鼠的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:欧广洋
-
依托单位:
肠道菌群的改变通过Trp/L-Kyn/AhR代谢通路介导ARDS免疫反应研究
-
批准号:2026JJ30097
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭小武
-
依托单位:
六君焦仙汤通过调节肠道菌群影响Trp/AhR通路治疗UC的作用机制研究
-
批准号:2026JJ80334
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李振龙
-
依托单位:
嗜黏蛋白阿克曼菌通过色氨酸代谢调节肝脏AhR-Srebp2 轴抑制肝癌的进展及机制研究
-
批准号:ZCLMS26H1602
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:闻良
-
依托单位:
基于KYN-AhR/CD8+T耗竭的解毒消癖方“解郁散结”抗乳腺癌作用机制研究
-
批准号:2026JJ82672
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:马思静
-
依托单位:
溃结宁膏穴位敷贴通过重塑肠道菌群调控ILA/AhR/MST1/NF-κB信号轴抑制巨噬细胞M1极化缓解溃疡性结肠炎的机制研究
-
批准号:2026JJ81966
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王燚霈
-
依托单位:
肠道菌群来源的色氨酸代谢物通过芳香烃受体(AhR)调控NMO中枢CD8+ T细胞浸润的机制研究
-
批准号:2026JJ80630
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周娟
-
依托单位: